Role of C5a and C5aR in doxorubicin‑induced cardiomyocyte senescence

Wen,Yahui; Shen,Feiyan; Wu,Haibin

doi:10.3892/etm.2021.10548

Role of C5a and C5aR in doxorubicin‑induced cardiomyocyte senescence

Authors:
- Yahui Wen
- Feiyan Shen
- Haibin Wu
View Affiliations

Affiliations: Medical Care Ward, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, P.R. China, Department of Cardiology, QingPu District Central Hospital, Shanghai 201700, P.R. China, Department of Outpatients, Shenzhen Traditional Chinese Medicine Hospital, Guangdong Shenzhen Health Management Center, Shenzhen, Guangdong 518033, P.R. China
Published online on: August 4, 2021 https://doi.org/10.3892/etm.2021.10548
Article Number: 1114
Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Doxorubicin (DOX) is an efficacious antineoplastic drug; however, its use is limited due to its cardiotoxicity. Cardiomyocyte senescence is considered to be a key factor in the development of DOX‑related cardiomyopathy. Complement component 5a (C5a) and the C5a receptor (C5aR) have been reported to play a key role in the process of cellular senescence. However, to the best of our knowledge, the exact role of C5a and C5aR in cellular senescence in the heart remains largely unknown. Reverse transcription‑quantitative (RT‑q)PCR and western blot assays were used to analyze the expression levels of C5a and C5aR in H9c2 embryonic rat cardiomyocytes and AC16 human cardiomyocyte‑like cells. The cells were treated with DOX and a C5aR antagonist (C5aRA). The expression of TNF‑α and IFN‑γ was determined using ELISA and western blotting. The levels of reactive oxygen species (ROS) were also measured using ELISA. Cellular senescence was determined using senescence‑associated β‑galactosidase (SA‑β‑gal) staining and by analyzing the protein expression levels of p53, p16, p21 and insulin‑like growth factor‑binding protein 3 (IGFBP3). The expression levels of C5a and C5aR were found to be upregulated during the DOX‑induced senescence of H9c2 and AC16 cardiomyocytes. Treatment with C5aRA downregulated TNF‑α and IFN‑γ expression, in addition to ROS levels. Furthermore, C5aRA prevented DOX‑induced cellular senescence and decreased the levels of positive SA‑β‑gal staining in H9c2 and AC16 cardiomyocytes, in addition to downregulating the expression levels of p53, p16, p21 and IGFBP3. C5aRA also increased the telomere length and telomerase activity in H9c2 and AC16 cardiomyocytes following DOX stimulation. In conclusion, the findings of the present study indicated that C5a and C5aR may play a key role in cardiomyocyte senescence, and treatment with C5aRA may be an effective method for preventing DOX‑induced cardiomyocyte aging.

View Figures

View References

1	Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W and Wang J: Oxidative stress in cell death and cardiovascular diseases. Oxid Med Cell Longev. 2019(9030563)2019.PubMed/NCBI View Article : Google Scholar
2	Tang X, Li PH and Chen HZ: Cardiomyocyte senescence and cellular communications within myocardial microenvironments. Front Endocrinol (Lausanne). 11(280)2020.PubMed/NCBI View Article : Google Scholar
3	Hernandez-Segura A, Nehme J and Demaria M: Hallmarks of cellular senescence. Trends Cell Biol. 28:436–453. 2018.PubMed/NCBI View Article : Google Scholar
4	Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, Reiter RJ, Qiao S and Yuan J: AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic Biol Med. 129:59–72. 2018.PubMed/NCBI View Article : Google Scholar
5	Zhang YW, Shi J, Li YJ and Wei L: Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz). 57:435–445. 2009.PubMed/NCBI View Article : Google Scholar
6	Singh P, Sharma R, McElhanon K, Allen CD, Megyesi JK, Beneš H and Singh SP: Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med. 86:90–101. 2015.PubMed/NCBI View Article : Google Scholar
7	Maejima Y, Adachi S, Ito H, Hirao K and Isobe M: Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell. 7:125–136. 2008.PubMed/NCBI View Article : Google Scholar
8	Guo RF and Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol. 23:821–852. 2005.PubMed/NCBI View Article : Google Scholar
9	Phieler J, Chung KJ, Chatzigeorgiou A, Klotzsche-von Ameln A, Garcia-Martin R, Sprott D, Moisidou M, Tzanavari T, Ludwig B, Baraban E, et al: The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J Immunol. 191:4367–4374. 2013.PubMed/NCBI View Article : Google Scholar
10	Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, et al: Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect. 7(77)2018.PubMed/NCBI View Article : Google Scholar
11	Yu S, Wang D, Huang L, Zhang Y, Luo R, Adah D, Tang Y, Zhao K and Lu B: The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages. J Biol Chem. 294:8384–8394. 2019.PubMed/NCBI View Article : Google Scholar
12	Merle NS, Grunenwald A, Rajaratnam H, Gnemmi V, Frimat M, Figueres ML, Knockaert S, Bouzekri S, Charue D, Noe R, et al: Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. JCI Insight. 3(e96910)2018.PubMed/NCBI View Article : Google Scholar
13	Vlaicu SI, Tatomir A, Boodhoo D, Vesa S, Mircea PA and Rus H: The role of complement system in adipose tissue-related inflammation. Immunol Res. 64:653–664. 2016.PubMed/NCBI View Article : Google Scholar
14	Martin IV, Bohner A, Boor P, Shagdarsuren E, Raffetseder U, Lammert F, Floege J, Ostendorf T and Weber SN: Complement C5a receptors C5L2 and C5aR in renal fibrosis. Am J Physiol Renal Physiol. 314:F35–F46. 2018.PubMed/NCBI View Article : Google Scholar
15	Brennan FH, Gordon R, Lao HW, Biggins PJ, Taylor SM, Franklin RJ, Woodruff TM and Ruitenberg MJ: The Complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury. J Neurosci. 35:6517–6531. 2015.PubMed/NCBI View Article : Google Scholar
16	Leaker BR, Malkov VA, Mogg R, Ruddy MK, Nicholson GC, Tan AJ, Tribouley C, Chen G, De Lepeleire I, Calder NA, et al: The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunol. 10:408–420. 2017.PubMed/NCBI View Article : Google Scholar
17	Yang B, Wang J, Zhao Y, Duan W, Dai C, Han Z, Wang M, Zhang B, Wei L, Chen Z and Chen D: Attenuating ischemia/reperfusion injury in rat cardiac transplantation by intracoronary infusion with siRNA cocktail solution. Biosci Rep. 40(BSR20193937)2020.PubMed/NCBI View Article : Google Scholar
18	Zhang XL, Ji XT, Sun B, Qian LL, Hu XL, Lou HX and Yuan HQ: Anti-cancer effect of marchantin C via inducing lung cancer cellular senescence associated with less secretory phenotype. Biochim Biophys Acta Gen Subj. 1863:1443–1457. 2019.PubMed/NCBI View Article : Google Scholar
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
20	Cawthon RM: Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 37(e21)2009.PubMed/NCBI View Article : Google Scholar
21	Tedone E, Huang E, O'Hara R, Batten K, Ludlow AT, Lai TP, Arosio B, Mari D, Wright WE and Shay JW: Telomere length and telomerase activity in T cells are biomarkers of high-performing centenarians. Aging Cell. 18(e12859)2019.PubMed/NCBI View Article : Google Scholar
22	Gupta SK, Garg A, Bär C, Chatterjee S, Foinquinos A, Milting H, Streckfuß-Bömeke K, Fiedler J and Thum T: Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression. Circ Res. 122:246–254. 2018.PubMed/NCBI View Article : Google Scholar
23	Huang PP, Fu J, Liu LH, Wu KF, Liu HX, Qi BM, Liu Y and Qi BL: Honokiol antagonizes doxorubicin-induced cardiomyocyte senescence by inhibiting TXNIP-mediated NLRP3 inflammasome activation. Int J Mol Med. 45:186–194. 2020.PubMed/NCBI View Article : Google Scholar
24	Afshar-Kharghan V: The role of the complement system in cancer. J Clin Invest. 127:780–789. 2017.PubMed/NCBI View Article : Google Scholar
25	Ajona D, Ortiz-Espinosa S and Pio R: Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. Semin Cell Dev Biol. 85:153–163. 2019.PubMed/NCBI View Article : Google Scholar
26	Sadik CD, Miyabe Y, Sezin T and Luster AD: The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Semin Immunol. 37:21–29. 2018.PubMed/NCBI View Article : Google Scholar
27	Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, et al: Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol. 28:2756–2767. 2017.PubMed/NCBI View Article : Google Scholar
28	Syed SN, Rau E, Ziegelmann M, Sogkas G, Brune B and Schmidt RE: C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice. Eur J Immunol. 48:696–704. 2018.PubMed/NCBI View Article : Google Scholar
29	Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY and Zhang KQ: Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation. Int Urol Nephrol. 50:1545–1553. 2018.PubMed/NCBI View Article : Google Scholar
30	Zhang C, Li Y, Wang C, Wu Y and Du J: Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension. Am J Hypertens. 27:857–864. 2014.PubMed/NCBI View Article : Google Scholar
31	Minguzzi M, Cetrullo S, D'Adamo S, Silvestri Y, Flamigni F and Borzi RM: Emerging players at the intersection of chondrocyte loss of maturational arrest, oxidative stress, senescence and low-grade inflammation in osteoarthritis. Oxid Med Cell Longev. 2018(3075293)2018.PubMed/NCBI View Article : Google Scholar
32	Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, et al: Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 14:1112–1120. 2013.PubMed/NCBI View Article : Google Scholar
33	Louzon M, Coeurdassier M, Gimbert F, Pauget B and de Vaufleury A: Telomere dynamic in humans and animals: Review and perspectives in environmental toxicology. Environ Int. 131(105025)2019.PubMed/NCBI View Article : Google Scholar
34	Victorelli S, Lagnado A, Halim J, Moore W, Talbot D, Barrett K, Chapman J, Birch J, Ogrodnik M, Meves A, et al: Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. EMBO J. 38(e101982)2019.PubMed/NCBI View Article : Google Scholar